Literature DB >> 7603414

Sleep features in Tourette's syndrome, neuroacanthocytosis and Huntington's chorea.

R Silvestri1, M Raffaele, P De Domenico, A Tisano, G Mento, C Casella, M C Tripoli, S Serra, R Di Perri.   

Abstract

Twenty-one patients affected by extrapyramidal disorders were polygraphically recorded during spontaneous nocturnal sleep for two consecutive nights to assess their sleep and movement patterns. The patients (pts) sample included: Gilles de La Tourette syndrome (TS, nine pts), neuroacanthocytosis (NA, six pts) and Hungtington's chorea (HC, six pts). Sleep recording included C3/A2, 01/A2, ROC/LOC, submental EMG, EKG, nasal airflow thoracoabdominal respirogram, bilateral anterior tibialis and other EMGs, in relation to the individual distribution of the abnormal movements. According to our observations, abnormal movements always decreased but never ceased completely during sleep. Sleep efficiency (SE) was nearly always poor with a high percentage of wakefulness after sleep onset (WASO) and increased number of arousals. REM sleep was often reduced and in some cases (3 TS pts) incompletely defined as far as its microstructural aspects. Slow wave sleep (SWS) was reduced in HC, normal in NA, and increased in all TS patients with the exception of the two adult subjects more severely affected, while the percentage of stage 2 was not affected. Spindling was increased in NA, HC and in the two most severely affected adult TS patients.

Entities:  

Mesh:

Year:  1995        PMID: 7603414     DOI: 10.1016/0987-7053(96)81034-3

Source DB:  PubMed          Journal:  Neurophysiol Clin        ISSN: 0987-7053            Impact factor:   3.734


  18 in total

1.  Huntington's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

2.  Inter-expert and intra-expert reliability in sleep spindle scoring.

Authors:  Sabrina L Wendt; Peter Welinder; Helge B D Sorensen; Paul E Peppard; Poul Jennum; Pietro Perona; Emmanuel Mignot; Simon C Warby
Journal:  Clin Neurophysiol       Date:  2014-11-10       Impact factor: 3.708

Review 3.  'The clocks that time us'--circadian rhythms in neurodegenerative disorders.

Authors:  Aleksandar Videnovic; Alpar S Lazar; Roger A Barker; Sebastiaan Overeem
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

4.  Nocturnal Post-arousal Chorea and Repetitive Ballistic Movement in Huntington's Disease.

Authors:  Surabhi Ranjan; Scott Kohler; Madaline B Harrison; Mark Quigg
Journal:  Mov Disord Clin Pract       Date:  2015-11-27

Review 5.  How vital is sleep in Huntington's disease?

Authors:  Anna O G Goodman; Roger A Barker
Journal:  J Neurol       Date:  2010-03-24       Impact factor: 4.849

6.  Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease.

Authors:  A Jennifer Morton; Nigel I Wood; Michael H Hastings; Carrie Hurelbrink; Roger A Barker; Elizabeth S Maywood
Journal:  J Neurosci       Date:  2005-01-05       Impact factor: 6.167

7.  Changes in sleep spindle activity of subject with chronic somatosensitive and sensorial deficits. Preliminary results.

Authors:  A Scrofani; M Cioni; S Filetti; F Lanaia; G Pennisi; R Bella; A Grasso
Journal:  Ital J Neurol Sci       Date:  1996-12

8.  The use of the Actiwatch-Neurologica system to objectively assess the involuntary movements and sleep-wake activity in patients with mild-moderate Huntington's disease.

Authors:  Carrie B Hurelbrink; Simon J G Lewis; Roger A Barker
Journal:  J Neurol       Date:  2005-03-07       Impact factor: 4.849

9.  Identifying sleep disturbances in Huntington's disease using a simple disease-focused questionnaire.

Authors:  Anna O G Goodman; A Jennifer Morton; Roger A Barker
Journal:  PLoS Curr       Date:  2010-10-15

10.  Early-onset sleep defects in Drosophila models of Huntington's disease reflect alterations of PKA/CREB signaling.

Authors:  Erin D Gonzales; Anne K Tanenhaus; Jiabin Zhang; Ryan P Chaffee; Jerry C P Yin
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.